PriceTargets.com logo

Doximity - DOCS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $55.00
  • Forecasted Upside: 49.90%
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 2 Hold Ratings
  • 2 Buy Ratings
  • 3 Strong Buy Ratings
$36.69 As of 02/2/2026 10:08 AM ET
▼ -0.78 (-2.08%)

This chart shows the closing price for DOCS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Doximity Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for DOCS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for DOCS

Analyst Price Target is $55.00
▲ +49.90% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Doximity in the last 3 months. The average price target is $55.00, with a high forecast of $55.00 and a low forecast of $55.00. The average price target represents a 49.90% upside from the last price of $36.69.

This chart shows the closing price for DOCS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 7 contributing investment analysts is to buy stock in Doximity.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/8/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/7/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
8/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2025
  • 1 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/2/2026
  • 3 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2026

Latest Recommendations

  • 3 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
1/26/2026Zacks ResearchUpgradeHold ➝ Strong-Buy
1/20/2026Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$55.00
1/9/2026The Goldman Sachs GroupUpgradeStrong Sell ➝ Hold
1/8/2026Truist FinancialUpgradeHold ➝ Strong-Buy
1/8/2026Royal Bank Of CanadaUpgradeModerate Buy
12/24/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
12/18/2025Weiss RatingsReiterated RatingHold (C+) ➝ Hold (C+)
12/12/2025Weiss RatingsInitiated CoverageHold (C+) ➝ Hold (C+)
12/8/2025BarclaysUpgradeStrong-Buy
(Data available from 2/2/2021 forward)

News Sentiment Rating

0.42 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025
  • 3 very positive mentions
  • 1 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
1/3/2026
  • 5 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
2/2/2026

Current Sentiment

  • 5 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Doximity logo
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States. The company's cloud-based platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers. It primarily serves pharmaceutical companies and health systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Read More

Today's Range

Now: $36.69
Low: $36.69
High: $36.69

50 Day Range

MA: N/A

52 Week Range

Now: $36.69
Low: $36.69
High: $85.21

Volume

4,854 shs

Average Volume

2,549,755 shs

Market Capitalization

$6.91 billion

P/E Ratio

29.12

Dividend Yield

N/A

Beta

1.39

Frequently Asked Questions

What sell-side analysts currently cover shares of Doximity?

The following Wall Street analysts have issued reports on Doximity in the last year: Barclays PLC, Royal Bank Of Canada, The Goldman Sachs Group, Inc., Truist Financial Corporation, Wall Street Zen, Weiss Ratings, Wells Fargo & Company, and Zacks Research.
View the latest analyst ratings for DOCS.

What is the current price target for Doximity?

0 Wall Street analysts have set twelve-month price targets for Doximity in the last year. Their average twelve-month price target is $55.00, suggesting a possible upside of 46.8%. Wells Fargo & Company has the highest price target set, predicting DOCS will reach $55.00 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $55.00 for Doximity in the next year.
View the latest price targets for DOCS.

What is the current consensus analyst rating for Doximity?

Doximity currently has 2 hold ratings, 2 buy ratings and 3 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe DOCS will outperform the market and that investors should add to their positions of Doximity.
View the latest ratings for DOCS.

What other companies compete with Doximity?

Other companies that are similar to Doximity include Zoom Communications, Wipro, CyberArk Software, Nebius Group and Check Point Software Technologies. Learn More about companies similar to Doximity.

How do I contact Doximity's investor relations team?

Doximity's physical mailing address is 500 THIRD STREET, SAN FRANCISCO, CA, 94107. The company's listed phone number is (650) 549-4330 and its investor relations email address is [email protected]. The official website for Doximity is doximity.com. Learn More about contacing Doximity investor relations.